0001461859-17-000003.txt : 20170127 0001461859-17-000003.hdr.sgml : 20170127 20170126181419 ACCESSION NUMBER: 0001461859-17-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170127 DATE AS OF CHANGE: 20170126 EFFECTIVENESS DATE: 20170127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVENTRIX INC CENTRAL INDEX KEY: 0001283259 IRS NUMBER: 200372415 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-267692 FILM NUMBER: 17551207 BUSINESS ADDRESS: STREET 1: 12647 ALCOSTA BLVD. STREET 2: SUITE 400 CITY: SAN RAMON STATE: CA ZIP: 94583 BUSINESS PHONE: 925-830-1000 MAIL ADDRESS: STREET 1: 12647 ALCOSTA BLVD. STREET 2: SUITE 400 CITY: SAN RAMON STATE: CA ZIP: 94583 FORMER COMPANY: FORMER CONFORMED NAME: CHF TECHNOLOGIES INC DATE OF NAME CHANGE: 20040310 D/A 1 primary_doc.xml X0707 D/A LIVE 0001283259 BIOVENTRIX INC 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 925-830-1000 DELAWARE CHF TECHNOLOGIES INC Corporation true KENNETH MILLER 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Executive Officer Director MICHAEL TAGLICH 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director STEVEN HEALY 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director PAUL SEID 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director WARREN E. PINKERT II 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director GEORGE FAZIO 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director ROBERT TAGLICH 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director Other Decline to Disclose 06b true 0001461859-16-000030 2016-07-21 false true CONVERTIBLE NOTES false 0 TAGLICH BROTHERS, INC. None None None 790 NEW YORK AVENUE SUITE 209 HUNTINGTON NY NEW YORK 11743 All States false 11250000 7895568 3354432 false 127 900000 true 0 Placement Agent also to receive warrants to purchase common stock equal to 10% of the number of shares of Common Stock the Notes are convertible into at an exercise price of $7.50 per share. 500000 true false BIOVENTRIX INC /s/Kenneth Miller KENNETH MILLER CEO 2017-01-26